You are here: Industry Insights > Glenmark pharma

News List

Glenmark Pharma gets US FDA approval for skin cream generic expresspharma
March 25, 2020
According to IMS Health sales data for the 12 months to May 2017, Desonide Cream, 0.05 per cent, achieved annual sales of approximately USD 44.6 million, Glenmark said.
Glenmark Pharma gets US FDA nod for cholesterol lowering drug expressbpd
June 28, 2019
The approved products, Ezetimibe and Simvastatin tablets in the strengths of 10 mg/10 mg, 10 mg/20 mg, 10 mg/40 mg, and 10 mg/80 mg, is a generic version of MSD International’s Vytorin tablets
Glenmark Pharma says US FDA has issued CRL for Ryaltris expressbpd
June 27, 2019
The CRL cites deficiencies in the Drug Master File pertaining to one of the active pharmaceutical ingredients and in manufacturing facilities, the company said in a regulatory filing
Glenmark Pharma Gets Tentative Nod From US FDA For Acne Treatment Drug expresspharma
June 21, 2019
Glenmark Pharmaceuticals said that it has received tentative approval from the US health regulator for Clindamycin Phosphate Foam, used to treat acne. The approved product is a generic version of Mylan Pharmaceuticals’ Evoclin Foam.
Glenmark Pharma launches Seretide Accuhaler financialexpress
May 21, 2018
Glenmark Pharmaceuticals has launched a generic version of Seretide Accuhaler, used to treat asthma, in Denmark.
Glenmark Pharma to present updated info on GBR 830 at International Investigative Dermatology Meeting expressbpd
May 11, 2018
Glenmark Pharma has announced that new and updated data on GBR 830 will be presented at the upcoming International Investigative Dermatology Meeting (IID) in Orlando, Florida.
Glenmark Pharma receives ANDA approval for nitroglycerin sublingual tablets expressbpd
September 21, 2017
IMS Health estimates annual sales of approx $112.7 million for these three strenghts of Nitrostat® Sublingual Tablets
Glenmark Pharma in agreement with Cyndea expressbpd
July 20, 2017
Under the agreement, Glenmark and Cyndea will partner to develop, license, manufacture and supply for commercialisation generic soft‐gelatin capsule drug products
Glenmark Pharma receives approval for Indomethacin extended-release capsules expressbpd
June 28, 2017
According to IMS health, Indocin SR extended‐release capsules, 75 mg market achieved annual sales of approximately $6.3 million in April 2017
Glenmark Pharma receives tentative ANDA approval for solifenacin succinate tabs expressbpd
June 26, 2017
According to IMS Health, the Vesicare tablets, 5 mg and 10 mg market achieved annual sales of approximately $1.1 billion